1,2,3,5-Tetrahydro-4,1-benzoxazepine, 98%, 100mg

2-(2-Chlorophenyl)ethanol>97.0%(GC)5g

2-(1-Naphthyl)-5-phenyloxazole [for scintillation spectrometry]>99.0%(HPLC)(N)1g

6,7-DIMETHYL-1H-INDOLE-2-CARBOXYLIC ACID, 95%, 100mg

2-Amino-3-bromopyridine, 98.0%, 10g

Ethyl Indane-5-carboxylate, 95.0%, 1g

1,1,1,3,3,3-Hexafluoro-2-propanol (HFIP) , 25mL, >=99%, for peptide synthesis

2-Isopropyl-2,8-diazaspiro[4.5]decan-3-one, 97.0%, 250mg

1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), min. 98%, for synthesis, 250 ml, glass packaging

7-Chloro-6-(trifluoromethyl)-3,4-dihydronaphthalen-1(2H)-one, 95.0%, 100mg

4-(Aminomethyl)-N-(3-cyano-4-methyl-1H-indol-7-yl)benzenesulfonamide, 98%, 500mg

3-Methylisoxazole-4-carboxylic acid, 97.0%, 1g

4-Bromo-6-methylpyridazin-3(2H)-one, 95.0%, 250mg